CORZ · Investment summary · as of 12 August 2026
Priced for an operating path the record does not support
Business type: Capital scale-up · scaling but economically observable
The business does not meet the quality standard for its economic type.
At $20.85, CORZ requires a 71% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 26%.
The disagreement with the market is about the RATE at which contracted megawatts convert into revenue, not about the margin earned on them.
The value rests on an exit multiple of 9.8x, a terminal operating margin of 30% and a 11.0% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: Permanent impairment of the equity through a counterparty credit event at one of two customers, transmitted through a capital structure that is levered against those same contracts.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | The disagreement with the market is about the RATE at which contracted megawatts convert into revenue, not about the margin earned on them. |
| What do we forecast? | Revenue growth of 26% demonstrated; a terminal operating margin of 30%; an exit multiple of 9.8x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is -44.9 percentage points. |
| What is it worth? | Twelve-month target $14.70, -29% from the struck price. Scenario-weighted expected return net of costs -29.5%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| 23 October 2026 | Next results (date estimated, not issuer-confirmed) | Revenue and margin in line with, or above, the house path | A miss that moves the full-year path below the guided floor |
| Q2 2027 (reported ~August 2027) | The near-term half of the revenue ramp, which is the least… | Neither leg of the condition opposite is met at this date | Billable customer power capacity fails to reach 590MW by the Q2 2027 report |
| Any two consecutive quarters from Q3 2026 | The 30% terminal EBIT margin is built down from a 59% segment gross… | Colocation segment gross margin falls at or above 50% in two consecutive quarters. | Colocation segment gross margin falls below 50% in two consecutive quarters. |
| Q4 2027 (reported ~February 2028) | The diversification thesis and the second half of the ramp. | Neither leg of the condition opposite is met at this date | AMD initial delivery does not commence billing by the Q4 2027 report, against management's stated 'early 2027' initial… |
Dates marked as estimated are drawn from the company’s own reporting cadence, not from an announcement.
Permanent impairment of the equity through a counterparty credit event at one of two customers, transmitted through a capital structure that is levered against those same contracts. The named cause is not 'demand for AI capacity falls'; it is that CORZ has converted a merchant business into a two-name credit exposure and financed it with $3.3bn of secured notes whose debt-service reserve is already funded from restricted cash. Mechanisms, each sourced: (1) CONCENTRATION — colocation is 83.2% of Q2 2026 revenue and essentially all of it is CoreWeave; the AMD/Neocloud leases signed 27 July 2026 add a second name but do not begin billing until 2027, so through the whole of the next twelve months the revenue base remains effectively single-name.
Estimated probability 25%, against the 18% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.
Falsifiable and fundamental — not one of them is a price condition.
On approach to the $14.70 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Not met | Is the business worth owning under its declared economic type? |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Met | Permanent impairment of the equity through a counterparty credit event at one of two customers, transmitted through a capital structure that is levered against those same contracts. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -44.9 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: permanent impairment of the equity through a counterparty credit event at one of two customers, transmitted through a capital structure that is levered against those same contracts. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $15.64, which forces an immediate review.